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RESUMO 
 
O objetivo do presente estudo foi avaliar a relação entre pacientes com doença 
pulmonar obstrutiva crônica (DPOC) e o risco de suicídio. Trata-se de uma revisão 
sistemática de estudos de coorte e caso-controle, que testaram a doença pulmonar 
obstrutiva crônica como fator de risco para o suicídio, sem restrição quanto ao ano, 
idioma e status de publicação. Foi elaborado protocolo e registro no PROSPERO e 
seguido as recomendações PRISMA e Cochrane. Utilizadas como fontes de estudo 
primárias nove bases de dados eletrônicas: Literatura Latino-Americana e do Caribe 
em Ciências da Saúde (LILACS), PubMed (incluindo MedLine), SciELO, Scopus, 
LIVIVO, Web of Science e PsychNET. Utilizou-se também o Open Thesis e o Open 
Grey na busca da literatura cinzenta para evitar o viés de seleção e publicação. A 
seleção dos estudos ocorreu em três fases conforme recomendação PRISMA e 
Cochrane por três revisores. A qualidade metodológica e o risco de viés dos estudos 
foram avaliados pela ferramenta “Joanna Briggs Institute Critical Appraisal Tools for 
Systematic Reviews”. Na meta-análise utilizou-se modelo de efeitos aleatórios para 
estimar a variação em odds ratios (OR) e os intervalos de confiança (IC95%) dos 
valores reportados pelos estudos elegíveis. A heterogeneidade entre os estudos foi 
avaliada pelo qui-quadrado (I2). A qualidade das evidências e a força de 
recomendação foram avaliadas pelo GRADE e considerada moderada. A busca final 
resultou em 4762 registros, onde após revisão sistemática, sete artigos preencheram 
os critérios de elegibilidade e foram incluídos. Os estudos foram publicados entre 
2002 e 2015, sendo cinco de caso-controle e dois de coorte. Nos sete estudos 
elegíveis a amostra total foi de 1390 casos de suicídio de pessoas com doença 
pulmonar obstrutiva crônica. Todos os estudos apresentaram baixo risco de viés. Na 
meta-análise constatou-se que pessoas portadoras de DPOC possuem maior 
chance de suicídio (OR=1,90; IC95%=1,27-2,48; p=0,002). A heterogeneidade entre 
os estudos foi caracterizada alta.  Assim, conclui-se que pacientes com DPOC 
formam um grupo de maior risco para cometer suicídio. 
 
Palavras-chave: Doença Pulmonar Obstrutiva Crônica. Fatores de risco. Suicídio.  
 
 
 
 
 
  
ABSTRACT 
 
The objective of the present study is to evaluate the relationship between patients 
with chronic obstructive pulmonary disease (COPD) and the risk of suicide. This is a 
systematic review of cohort and case-control studies that tested chronic obstructive 
pulmonary disease as a risk factor for suicide, without restriction regarding year, 
language, and publication status. Protocol and registry were elaborated in the 
PROSPERO and followed the recommendations PRISMA and Cochrane. Four 
electronic databases were used as primary sources of study: Latin American and 
Caribbean Literature in Health Sciences (LILACS), PubMed (including MedLine), 
SciELO, Scopus, LIVIVO, Web of Science and PsychNET. The Open Thesis and the 
Open Gray were used to search for gray literature and avoid selection and 
publication bias. The selection of studies was performed in three phases according to 
PRISMA and Cochrane recommendations by three reviewers. The methodological 
quality and risk of study bias were evaluated by the Joanna Briggs Institute Critical 
Appraisal Tools for Systematic Reviews tool. The meta-analysis used a random 
effects model to estimate the odds ratio (OR) and confidence intervals (95% CI) of 
the values reported by the eligible studies. The heterogeneity between the studies 
was assessed by chi-square (I2). The quality of the evidence and the 
recommendation strength were evaluated by GRADE and considered moderate. The 
final search resulted in 4762 records, which after systematic review, seven articles 
met the eligibility criteria and were included. The studies were published between 
2002 and 2015, of which five were case-control and two were cohort studies. The 
total sample was 1390 cases of suicide of people with chronic obstructive pulmonary 
disease. All studies were at low risk of bias. The meta-analysis found that people with 
COPD had a higher risk of suicide (OR = 1.90, 95% CI = 1.27-2.48, p = 0.002). The 
heterogeneity between the studies was characterized as high. Thus, it is concluded 
that COPD patients form a higher-risk group (1.9) to commit suicide. 
 
Keywords: Chronic obstructive pulmonary disease. Risk factors. Suicide. 
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1 INTRODUÇÃO 
  
O suicídio é a 17ª causa mais frequente de óbito no mundo, com cerca de 
788 mil suicídios apenas em 2015 (Organização Mundial de Saúde, 2015). No Brasil  
foram notificadas, entre 2011 e 2016, 62.804 mortes por suicídio. (Ministério da 
Saúde, 2016). Em 2016, foram registradas 11.433 óbitos por lesões autoprovocadas 
voluntariamente, a maioria (62%) por enforcamento (Ministério da Saúde, 
2016).  Sendo considerado um fenômeno complexo, multifatorial, cuja ocorrência 
não pode ser atribuída a uma única característica ou evento (Shao et al., 2016). 
Diversos estudos ao redor do mundo já estabeleceram algumas condições 
predisponentes ao suicídio, como doenças crônicas (Barker et al., 2015), transtornos 
mentais (Erlangsen et al., 2012), asma (Barker et al., 2015), dores crônicas (Spiegel 
et al., 2007), doenças cardiovasculares, doença cardíaca isquêmica, câncer, 
diabetes, insuficiência renal e baixa qualidade de vida (Joshi et al., 2017).  
A Doença Pulmonar Obstrutiva Crônica (DPOC) é uma doença comum 
caracterizada pela obstrução parcial dos brônquios aliada a inflamação pulmonar 
anormal como reação a exposições significativas a partículas e gases nocivos 
(Littner, 2011; GOLD, 2017), causada principalmente pela exposição ao tabaco e a 
outros poluentes ambientais (GOLD, 2017). Existem cerca de 175 milhões de 
pessoas com DPOC em todo o mundo (GBD 2015 Chronic Respiratory Disease 
Collaborators, 2017), em curva crescente de notificações. Somente em 2015, 
estima-se que três milhões de pessoas diagnosticadas com DPOC foram a óbito 
(GBD 2015 Chronic Respiratory Disease Collaborators, 2017) e espera-se que até 
2020 a DPOC torne-se a terceira maior causa de mortes no mundo (Mannino & 
Buist, 2007; Lozano et al., 2012).  
Os sintomas da DPOC são dispneia, tosse com ou sem expectoração, 
sibilos e opressão torácica. (Miravitlles M & Ribera A, 2017). Sendo a dispneia 
progressivamente incapacitante no decorrer da doença, os portadores da DPOC 
apresentem grandes limitações no dia a dia, com intenso prejuízo na realização de 
atividades básicas da vida diária, reduzindo sua qualidade de vida (Baltieri et al., 
2017). Por conta disso, grande número de indivíduos com DPOC desenvolvem 
transtornos de ansiedade ou de depressão, com prevalência próxima a 96% dos 
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pacientes (Godoy et al., 2009; Atlantis et al., 2013; Hegerl et al., 2014; Salte et al., 
2015).  
O transtorno depressivo e suicídio estão relacionados ao hábito do 
tabagismo,  a principal causa de DPOC (Fluharty et al, 2016; Poorolajal  & Darvishi, 
2010). Também notou-se no estudo de Clyde et al (2013) que o hábito do tabagismo 
está associado à depressão. Assim como as pessoas portadoras de transtorno 
depressivo sentem-se estimuladas a fumar (Mathew et al, 2017).   
Após o diagnóstico, as pessoas com DPOC são aconselhadas e 
estimuladas a abandonarem o habito do tabagismo para reduzirem a progressão da 
doença (Kaplan A, Thomas M, 2017). A nicotina presente no tabaco é substância 
psicoativa atuando nos receptores dopaminérgicos do núcleo accumbens e no corpo 
estriado (Di Matteo et al, 2007). A estimulação dos receptores dopaminérgicos 
provocam diversos comportamentos como: melhora na atenção e memória, controle 
da ansiedade, aumento da autoestima e autoconfiança e a modulação do humor 
(Faure et al, 2014).  Considerando a necessidade do abandono do tabagismo e a 
associação entre dependência da nicotina e depressão (Dierker L et al, 2015), na 
interrupção do hábito de fumar a síndrome de abstinência pode apresentar sintomas 
depressivos. 
Associado à depressão e à ansiedade, a literatura tem relatado maior 
tendência de suicídio entre os pacientes que sofrem com esses transtornos (Ciulla et 
al., 2014; Hawton et al., 2013; Brown et al., 2017). Por grande parte dos pacientes 
com DPOC apresentarem alguns sintomas de ansiedade ou depressão, esses 
podem representar um grupo de risco ao suicídio (Miravitlles et al., 2014; Fritzsche et 
al., 2014).  
Estudos têm demonstrado que esses sintomas estão relacionados à difícil 
adaptação dos indivíduos com DPOC a sua condição de saúde, principalmente no 
que diz respeito à dificuldade em realizar tarefas rotineiras, dando-lhes a sensação 
de invalidez (Kayahan et al., 2006; Katz et al., 2010).  
A partir de estudos de revisões sistemáticas que revelam a associação de 
suicídio com diversas causas. E considerando-se a pesquisa com início na ciência 
básica e sua conclusão na aplicação prática do conhecimento apreendido 
(translacional). Para completar a lacuna que falta na literatura, o objetivo do presente 
estudo é avaliar a relação entre pacientes com DPOC e o risco para suicídio.  
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2 ARTIGO 
Artigo submetido ao periódico Respiratory Medicine (Anexo 1) 
Fator de Impacto: 3.29 
 
Chronic obstructive pulmonary disease as a risk factor for suicide: A 
systematic review and meta-analysis. 
 
ABSTRACT 
Background: Patients living with chronic obstructive pulmonary disease (COPD) 
commonly present several limitations in their daily activities, high depression rates, 
and low quality of life, which makes this population a risk group for suicide. This 
study aims to systematically assess the literature on the association between CPOD 
and the likelihood of suicide. 
Methods: The protocol was registered in PROSPERO (CRD42018096618). The 
Latin-American and Caribbean Health Sciences Literature (LILACS), PubMed 
(including MedLine), SciELO, Scopus, LIVIVO, Web of Science, and PsychNET 
databases were used as primary study sources. OpenThesis and OpenGrey were 
used to partially capture the "grey literature". A manual search was also performed 
through a systematized analysis of the references of eligible articles. The risk of bias 
among the studies included was assessed with the Joanna Briggs Institute Critical 
Appraisal Tools for Systematic Reviews. Because of the high heterogeneity among 
studies (I²=95%), a random effects meta-analysis was performed to estimate the 
variation in odds ratio (OR) and 95% confidence intervals (95% CI). 
Results: The search provided 4762 results, from which only seven met the eligibility 
criteria and were ultimately included in the qualitative assessment of the review. The 
studies were published from 2002 to 2015. All studies presented low risk of bias. The 
total sample included 1390 suicide cases of COPD patients. The meta-analysis, 
which was based on five eligible case control studies, found that people with history 
of COPD are more likely to commit suicide (OR = 1.90; 95% CI = 1.27-2.48; 
p=0.002). Conclusion: COPD patients are 1.9 times more likely to commit suicide 
than people without COPD. 
Keywords: Chronic obstructive pulmonary disease; Suicide; Risk factors. 
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INTRODUCTION 
Chronic Obstructive Pulmonary Disease (COPD) is a common disease 
characterized by partial bronchial obstruction combined with an abnormal pulmonary 
inflammation that occurs as a reaction to significant exposures to harmful particles 
and gases.1,2 It is especially caused by the exposure to tobacco and other 
environment pollutants.2 There are around 175 million people with COPD worldwide 
in an increasing reporting curve.3 
Considering that COPD is a highly disabling disease, patients present 
great daily life limitations and low quality of life.1,4 This implies a difficult adaptation 
process of individuals with COPD to their health condition, especially concerning the 
challenges of performing routine tasks and nicotine withdrawal.5,6 Hence, a high 
number of individuals with COPD develop anxiety or depression disorders,7-10 with a 
mean prevalence of 27.1% of patients.7 In addition, depression increases COPD 
symptoms, revealing double and positive associations between CPOD and 
depression.8 
Studies have reported a higher suicide tendency among patients that who 
suffer from depression and anxiety,11-13 chronic diseases,3 mental disorders,14 
asthma,3 chronic pain,15 cardiovascular diseases, ischemic heart diseases, cancer, 
diabetes, renal failure, and low quality of life.16 In this regard, studies have also 
shown a higher tendency of individuals with COPD to present suicidal ideas or 
behaviours.17-20 
It is estimated that three million people diagnosed with COPD have died in 
2015.21 Currently, this disease is among the three main causes of death over the last 
decade, especially affecting people older than 55 years.22,23 
Considering the extent and potential of the health impact caused by this 
disease, especially because it may be fatal, this systematic review aims to assess the 
likelihood of COPD patients to commit suicide and it was based on published studies 
with low risk of bias. The authors tested the following working hypothesis: COPD 
patients have a different likelihood to commit suicide than individuals without COPD. 
 
METHOD 
Protocol and registration 
This systematic review was performed according to the list of PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
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recommendations24 and the Cochrane guidelines.25 The systematic review protocol 
was registered in the PROSPERO database under no. CRD42018096618. 
 
Study design and eligibility criteria 
 
This study was a systematic review that aimed to answer the following 
clinical question: “Are patients diagnosed with chronic obstructive pulmonary disease 
more likely to commit suicide than those without this disease?” 
Only cohort or case-control observational studies were included, which 
specifically tested chronic obstructive pulmonary disease as a risk factor for suicide, 
without restrictions of year, language, or publication status. Additionally, only studies 
that selected patients by ICD-10 (or previous versions) for suicide (X60-X84) and 
COPD (J44) were included. 
The exclusion criteria were: 1) Studies not related to the topic; 2) Review 
articles, letters to the editor/editorials, personal opinions, books/book chapters, 
textbooks, reports, conference abstracts, and patents; 3) Completely descriptive 
studies; 4) Studies that grouped more than one pulmonary disease as one single risk 
factor and 5) Studies with high risk of bias. 
 
Sources of information and search 
The Latin-American and Caribbean Health Sciences Literature (LILACS), 
PubMed (including MedLine), SciELO, Scopus, LIVIVO, Web of Science, and 
PsychNET databases were used as primary study sources. OpenThesis and 
OpenGrey were used to partially capture the "grey literature". A manual search was 
also performed through a systematized analysis of the references of eligible articles. 
These steps aimed to minimize selection and publication biases. 
The MeSH (Medical Subject Headings) and DeCS (Health Sciences 
Descriptors) were used to select the search descriptors. The Boolean operators 
"AND" and "OR" were used to enhance the search strategy through several 
combinations. (Table 1). The bibliographic research was performed in May 2018. The 
search strategy included the following keywords: "Suicide", "Suicidal Ideation", 
"Pulmonary Disease, Chronic Obstructive", "Suicídio" [Portuguese], and their 
synonyms: "Suicides", "Suicide rate", "Fatal suicidal", "COPD", "Chronic Obstructive 
Pulmonary Disease", "Chronic Obstructive Airway Disease", "Chronic Obstructive 
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Lung Disease". The results obtained were exported to the EndNote Web™ software 
(Thomson Reuters, Toronto, Canada) and duplicates were removed. The remaining 
results were exported to Microsoft Word™ 2010 (Microsoft™ Ltd, Washington, USA) 
and the remaining duplicates were manually removed. 
 
Study selection 
The studies were selected in three phases. In the first phase, as a 
calibration exercise, the reviewers discussed the eligibility criteria and applied them 
to a sample of 20% of the studies retrieved to determine inter-examiner agreement. 
After achieving a proper level of agreement (Kappa: 0.81-0.85), the two eligibility 
reviewers (MSS and WAV) performed a methodical analysis of all the titles of the 
studies, independently. The reviewers were not blind to the names of authors and 
journals. Titles not related to the topic and books/book chapters were eliminated in 
this phase. In the second phase, the reviewers (MSS and WAV) read all the 
remaining abstracts, independently. At this stage, the abstracts not related to the 
topic, review studies, and completely descriptive studies were eliminated. Titles that 
met the objectives of the study, but did not have abstracts available, were fully 
considered in the third phase.  
The full texts of the eligible studies so far were obtained and evaluated to 
verify whether they fulfilled the eligibility criteria. In all phases, when both reviewers 
disagreed, a third reviewer (LRP) was consulted to make a final decision. The studies 
rejected were registered separately, explaining the reasons for exclusion. 
 
Data collection 
After the selection, two authors (MSS and WAV) analysed the studies, 
which data were extracted for the following information: Identification of the study 
(author, year, research location, type of study), sample characteristics (number of 
patients in each study), data collection characteristics (assessment time, sources of 
information, confirmation methods for COPD diagnosis), and main results. In order to 
ensure the consistency among reviewers, a calibration exercise was performed with 
both reviewers (MSS and WAV), in which information were extracted jointly from an 
eligible study. Any disagreement between the reviewers was solved through 
discussions and when both reviewers could not agree, a third one (LRP) was 
consulted to make a final decision. 
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Table 1 - Strategies for database search. 
Database Search strategy (May, 2018) Results 
  
LILACS 
http://lilacs.bvsalud.org/ 
  
tw:((DPOC AND suicídio)) AND (instance:"regional") AND ( 
db:("LILACS")) 
0 
tw:((Pulmonary Disease, Chronic Obstructive and Suicide)) 
AND (instance:"regional") AND ( db:("LILACS")) 
0 
tw:((COPD and Suicide)) AND (instance:"regional") AND ( 
db:("LILACS")) 
0 
tw:((Chronic Disease and Suicide)) AND (instance:"regional") 
AND ( db:("LILACS")) 
35 
tw:((Doenças Crônicas and Suicídio)) AND 
(instance:"regional") AND ( db:("LILACS")) 
17 
tw:((Chronic Illness and Suicide)) AND (instance:"regional") 
AND ( db:("LILACS")) 
12 
  
SciELO 
http://www.scielo.org/  
DPOC AND Suicídio 0 
Pulmonary Disease, Chronic Obstructive and Suicide 0 
COPD and Suicide 0 
Chronic Disease and Suicide 15 
Chronic Illness and Suicide 2 
Doenças Crônicas and Suicídio 3 
 
 
 
 
 
PubMed 
http://www.ncbi.nlm.nih.gov/pubmed 
 
((“Suicide”[MeSH Terms] OR “Suicide”[All Fields] OR 
“Suicides”[All fields] OR “Suicide rate”[All fields] OR “Suicidal 
Ideation”[MeSH Terms] OR “Suicidal Ideation”[All Fields] OR 
“Ideation, Suicidal”[All Fields] OR “Fatal suicidal”[All Fields]) 
AND (“Pulmonary Disease, Chronic Obstructive”[MeSH Terms] 
OR “Pulmonary Disease, Chronic Obstructive”[All Fields] OR 
“COPD”[All Fields] OR “Chronic Obstructive Pulmonary 
Disease”[All Fields] OR “COAD”[All Fields] OR “Chronic 
Obstructive Airway Disease”[All Fields] OR “Chronic 
Obstructive Lung Disease”[All Fields] OR “Airflow Obstruction, 
Chronic”[All Fields] OR “Airflow Obstructions, Chronic”[All 
Fields] OR “Chronic Disease”[MeSH Terms] OR “Chronic 
Disease”[All Fields] OR “Chronic Diseases”[All Fields] OR 
“Chronic Illness”[All Fields])) 
1158 
 
Scopus 
http://www.scopus.com/ 
(("Suicide" OR "Suicides" OR "Suicidal Ideation" OR "Ideation, 
Suicidal") AND ("Pulmonary Disease, Chronic Obstructive" OR 
"COPD" OR "Chronic Obstructive Pulmonary Disease" OR 
"Chronic Obstructive Airway Disease" OR "Chronic Disease")) 
1685 
 
Web of Science 
http://apps.webofknowledge.com/ 
((“Suicide” OR “Suicides” OR “Suicide rate” OR “Suicidal 
Ideation” OR “Ideation, Suicidal” OR “Fatal suicidal”) AND 
(“Pulmonary Disease, Chronic Obstructive” OR “COPD” OR 
“Chronic Obstructive Pulmonary Disease” OR “COAD” OR 
“Chronic Obstructive Airway Disease” OR “Chronic Obstructive 
Lung Disease” OR “Airflow Obstruction, Chronic” OR “Airflow 
Obstructions, Chronic” OR “Chronic Disease” OR “Chronic 
Diseases” OR “Chronic Illness”)) 
377 
LIVIVO 
https://www.livivo.de 
((“Suicide” OR “Suicides” OR “Suicidal Ideation” OR “Ideation, 
Suicidal”) AND (“Pulmonary Disease, Chronic Obstructive” OR 
“COPD” OR “Chronic Obstructive Pulmonary Disease” OR 
“Chronic Obstructive Airway Disease”)) 
248 
PsychNET 
http://psycnet.apa.org/ 
Any Field: “Suicide” OR “Suicides” OR “Suicide rate” OR 
“Suicidal Ideation” OR “Ideation, Suicidal” OR “Fatal suicidal” 
AND Any Field: “Pulmonary Disease, Chronic Obstructive” OR 
“COPD” OR “Chronic Obstructive Pulmonary Disease” OR 
“COAD” OR “Chronic Obstructive Airway Disease” OR 
“Chronic Obstructive Lung Disease” OR “Airflow Obstruction, 
Chronic” OR “Airflow Obstructions, Chronic” OR “Chronic 
Disease” OR “Chronic Diseases” OR “Chronic Illness” 
 
734 
OpenThesis 
http://www.openthesis.org/ 
 
("Suicide" or "Suicides" or "Ideation, Suicidal") AND 
("Pulmonary Disease, Chronic Obstructive" OR "Chronic 
Disease") 
474 
OpenGrey 
http://www.opengrey.eu/ 
("Suicide" OR "Suicides") and "Pulmonary" 2 
TOTAL                                                                                                                                                  4762 
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Risk of individual bias of the studies 
Two authors (LRP and WAV) assessed the risk of bias and individual 
quality of the studies selected, independently, using the Joanna Briggs Institute 
Critical Appraisal Tools for use in JBI Systematic Reviews26 for case-control and 
cohort studies. As a means of  calibration, the authors analysed an eligible study 
jointly, with the presence of a third reviewer (LRP) in charge of solving divergences in 
case of doubts.  
The following questions were used to assess the case-control studies: 1) 
Were the groups comparable other than the presence of disease in cases studies or 
the absence of disease in control studies? 2) Were cases and controls matched 
appropriately? 3) Were the same criteria used to identify cases and controls? 4) Was 
exposure measured in a standard, valid, and reliable way? 5) Was exposure 
measured in the same way for cases and controls? 6) Were confounding factors 
identified? 7) Were strategies to deal with confounding factors stated? 8) Were 
outcomes assessed in a standard, valid, and reliable way for cases and controls? 9) 
Was the exposure period of interest long enough to be significant? 10) Was 
appropriate statistical analysis used?  
The following questions were used to assess the cohort studies: 1) Were 
both groups similar and recruited from the same population? 2) Were the exposures 
measured similarly to assign people to both exposed and unexposed groups? 3) Was 
the exposure measured in a valid and reliable way? 4) Were confounding factors 
identified? 5) Were strategies to deal with confounding factors stated? 6) Were the 
groups/participants free of the outcome at the start of the study or at the time of 
exposure? 7) Were the outcomes measured in a valid and reliable way? 8) Was the 
follow-up time reported and long enough for outcomes to occur? 9) Was follow-up 
completed, and if not, were the reasons for interrupting follow-up described and 
explored? 10) Were there strategies to address incomplete follow-up? 11) Was 
appropriate statistical analysis used? 
The risk of bias was ranked as High when the study reached up to 49% of 
"yes" score, Moderate when the study reached from 50% to 69% of "yes" score, and 
Low when the study reached over 70% of "yes" score. Studies characterized as 
"high risk of bias" were excluded.27 
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Summary measures and syntheses of results 
The primary summary measured was the likelihood of COPD patients to 
commit suicide. This summary was reported in odds ratio (OR) and 95% confidence 
intervals. A meta-analysis using a random effects model was performed to estimate 
the variation in odds ratio (OR) and 95% confidence intervals (95% CI) of the values 
reported by the individual studies.25,28 The random model was used to minimize the 
heterogeneity effect among the studies,25 which was assessed using I2 statistics and 
classified as follows: low (I2 < 25%), moderate (I2 = 50%), and high (I2 > 75%).30 
There was high heterogeneity among the studies (I²=95%). The analyses were 
performed with the Review Manager, version 5.3 (RevMan, Cochrane Collaboration) 
and Stata, version 15.0 (Stata Corp., College Station, USA) software. 
 
Quality of evidence 
 
The Grading of Recommendation, Assessment, Development, and 
Evaluation (GRADE) tool30 assessed the quality of evidence and the grading of 
strength of recommendation. This assessment was based on study design, 
methodological limitations inconsistency, indirectness, imprecision, and other 
considerations. Quality of evidence was characterized as high, moderate, low, or 
very low.30 
 
RESULTS 
Study selection 
During the first phase of study selection, 4762 results were found in the 
nine electronic databases, including the grey literature. After removing the duplicate 
results, 2582 articles remained for the analysis of titles and abstracts. After a detailed 
search process, seven articles were eligible for the full text analysis. The references 
of these seven potentially eligible studies were carefully assessed and one more 
study was selected, resulting in eight studies for full text reading. Next, one study31 
did not fulfil the inclusion criteria and it was eliminated. Thus, only seven studies 
were selected for qualitative analysis and five were included in the meta-analysis. 
Figure 1 reproduces the process of search, identification, inclusion, and exclusion of 
articles. 
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Characteristics of eligible studies 
The studies were published between 2002 and 2015 and were performed 
in Canada,32-34 United Kingdom,35 Sweden,36 and Denmark.19,37 Five studies were 
case-controls19,32-35 and two were cohorts.36,37 The assessment time ranged from 
eight years35,36 to 26 years19 and the studies were performed from 198132 to 
2009.34,37 
Other sources of information regarding suicide (year, location, method) 
and the demographic characteristics of the population (age, income, housing, sex) of 
all studies19,32-37 were obtained from secondary data from local databases maintained 
by government agencies. The total sample included 1390 suicide cases of people 
diagnosed with COPD. In order to determine the COPD diagnosis, all studies19,32-37 
used government databases with data regarding the health conditions of the 
population, identifying people diagnosed with COPD by the ICD code (J44). Table 2 
shows details of the eligible studies. 
 
Risk of individual bias of the studies 
All eligible studies, both case-controls19,32-35 and cohorts36,37, presented 
100% of "yes" answers to the Joanna Briggs Institute Critical Appraisal Tools for use 
in JBI Systematic Reviews26, which means that all studies presented a low risk of 
bias/high methodological quality. 
 
Results of individual studies 
The studies by Crump et al. (2014)36 and Erlangsen et al. (2015)37 were 
removed from the meta-analysis of this review for presenting distinct study designs 
and analysis models (Hazard Ratios and Rates Ratios, respectively). However, the 
results of both studies36,37 showed a positive association between people with COPD 
and suicide (Table 2). The studies19,32-35 included in the quantitative analysis 
presented results ranging from 1.62 to 4.75 of likelihood of people with COPD to 
commit suicide.  Table 2 shows the specific results of each study. 
 
Synthesis of results and Meta-analysis 
Figure 2 shows the meta-analysis of case-control studies assessing the 
likelihood of suicide in the presence of COPD. History of COPD provided a higher 
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likelihood of suicide (OR = 1.90; 95% CI = 1.27-2.48; p = 0.002). The heterogeneity 
among studies was I²=95%, characterizing high heterogeneity. 
 
Quality of evidence 
Overall, the quality of evidence from the outcomes evaluated by the 
GRADE30 system was assessed as moderate (Table 3). 
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Figure 1 - Flowchart of the process of literature search and selection, adapted from 
the PRISMA statement.
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Table 2 - Summary of the main characteristics and outcomes of the eligible studies. 
Author, 
year 
Location Assessment 
time 
Source of 
information 
(suicide) 
Source of 
information 
(population) 
Sample (n) COPD confirmation method Main results 
Quan et al., 
200235 
Alberta, 
Canada 
11 years 
(1984-1995) 
Office of the Chief 
Medical Examiner of 
the Province of 
Alberta 
Demographic and 
Income Statistics for 
Postal Address; 
Alberta Health and 
Wellness database 
113 
(controls) 
133 (cases) 
Information collected by the 
medical records in the 
Manitoba Health Registry 
Alberta Health and Wellness 
database, using the ICD 
code for COPD 
Elderly men with COPD are more 
likely to commit suicide, especially 
when married (OR, 1.86; 95% CI, 
1.22-2.83). 
Juurlink et 
al., 200436 
Ontario, 
Canada 
9 years  
(1992 – 2000) 
Office of the Chief 
Coroner for Ontario 
Registered Persons 
Database 
583 
(controls) 
220 (cases) 
Information from the Ontario 
Benefit Program 
COPD is directly associated with 
suicide (OR, 1.62; 95% CI, 1.37-
1.92). 
Webb et 
al., 201238 
United 
Kingdom 
8 years 
(2001-2008) 
Office for National 
Statistics and 
General Register 
Offices 
General Practice 
Research Database 
329 
(controls) 
27 (cases) 
Information from the General 
Practice Research Database, 
using the ICD code for COPD 
COPD is directly associated with 
suicide (OR, 1.80; 95% CI,1.18-
2.76), and it is more prevalent 
among women (OR, 3.23; 95% 
CI, 1.57-6.66) than men (OR, 
1.41; 95% CI, 0.83-2.39) 
Crump et 
al., 201439 
Sweden 8 years 
(2001-2008) 
Swedish Death 
Registry (National 
Board of Health and 
Welfare) 
Swedish Population 
Registry  
89 suicides 
of people 
with COPD 
Information from the Swedish 
Out-patient Registry or 
Swedish Hospital Registry, 
using the ICD code for COPD 
COPD is associated with a higher 
rate of suicide among both 
women (HR, 3.05; 95% CI, 2.46-
3.79) and men (HR, 2.26; 95% CI, 
1.92-2.65) 
Bolton et 
al., 201437 
Manitoba, 
Canada 
14 years  
(1996-2009) 
Population Health 
Research Data 
Repository at the 
Manitoba Centre for 
Health Policy 
Population Health 
Research Data 
Repository at the 
Manitoba Centre for 
Health Policy 
101 
(controls) 
65 (cases) 
Information from the 
Manitoba Health Registry, 
using the ICD code for COPD 
COPD increases the risk of 
suicide (OR, 2.06; 95% CI, 1.48–
2.86) and it is more prevalent 
among women (OR, 4.75; 95% 
CI, 1.84–12.22) than men (OR, 
1.12; 95% CI, 0.70-1.79) 
Strid et al., 
201426 
Denmark 26 years  
(1981 – 2006) 
Cause-of-Death 
Registry 
Danish Civil 
Population System 
3087 
(controls) 
592 (cases) 
Information from the Danish 
National Patient Registry, 
using the ICD code for COPD 
Patients diagnosed with COPD 
and with history of hospitalization 
are more likely to commit suicide 
(OR 2.6; 95% CI, 2.3-2.8) 
Erlangsen 
et al., 
201540 
Denmark 20 years (1990-
2009) 
Cause of Death 
Registry 
Danish Civil 
Population Registry 
264 
suicides of 
people with 
COPD 
Information from the Danish 
National Patient Registry, 
using the ICD code for COPD 
People with COPD are more likely 
to commit suicide (RR, 1.73; 95% 
CI, 1.52-1.96) 
Abbreviations: COPD - Chronic Obstructive Pulmonary Disease; ICD - International Classification of Diseases; OR - Odds Ratio; CI - Confidence Interval; RR - Relative Risk; HZ - Hazard Ratio
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Figure 2 - Forest plot of the case-control studies, showing a higher likelihood of suicide in the presence of COPD.
 
Table 3. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Summary of Findings Table for the 
Outcomes of the Systematic Review and Meta-Analysis 
Quality Assessment                  Summary of Results Importanc
e 
Numbe
r of 
studies 
Study 
Desig
n 
Methodologic
al Limitations 
Inconsisten
cy 
Indirectne
ss 
Imprecisio
n 
Publicatio
n 
Biases 
Number of 
participants  
Effects General 
Quality 
Case 
group 
Control 
Gourp 
Random 
(95% CI) 
5 Case 
control 
studie
s 
√ √ √ √ √ 1119 3884 (OR = 1.90; 
95% CI = 
1.27-2.48 
+++ 
MODERATE 
Critical 
GRADE factors: = √, no serious limitations; X, serious limitation; 
General quality of evidence: +, very low; ++, low; +++, moderate; ++++, high 
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DISCUSSION 
The results of the present systematic review confirmed a positive 
association between COPD and suicide. Moreover, a person living with COPD is 
90% more likely to commit suicide than a person without COPD.  
Suicide is related to several factors, including social organization, family 
history, limitation of daily life activities, personality traits, and mental disorders38,39. 
Regarding mental disorders, depression has been strongly associated with suicide 
and suicidal behavior39. Some characteristics of people with depression aggravate 
the suicide outcome,such as the male sex, family history of psychiatric disorder, 
hopelessness, comorbid disorders, anxiety, and misuse of alcohol and drugs39. 
Additionally, a higher prevalence of suicide has been observed among older 
people,11,40-42 which is related to isolation, loss of a loved one, feeling of uselessness 
to the family, or even loss of autonomy43-46. Besides risk factors directly associated 
with suicide, it is observed that suicidal ideation is strongly  ssociated with the 
presence of moderate limitations in routine activities and the presence of severe 
pain42,47.  
Risk factors for suicide have been observed in people with COPD, which 
could help understanding the outcome of the meta-analysis developed in this study. 
The diagnosis of COPD is a major factor for developing depression and anxiety, and 
the presence of psychological disorders increases the likelihood of worsening COPD 
conditions.8 Moreover, great daily life limitations and low quality of life resulting from 
COPD have an influence on the development of psychological disorders.1,4 People 
with COPD are more likely to presente suicidal behaviours such as ideation or 
previous attempts.20,48 This potential relationship between risk factor for suicide and 
COPD may guide further studies, considering the link among such conditions has 
been rarely investigated49. The performance of prospective cohort studies following 
patients correctly diagnosed with COPD, either exposed to depression or not, is 
encouraged.  
Despite this confluence between risk factors for suicide and factors related 
to COPD, three eligible studies34-36 showed that women with COPD have a higher 
risk of committing suicide than men with COPD. These results contradict the 
international literature, which has shown that men are more related to suicide.50,51 
Therefore, the relationship between sex and suicide is not clear and further studies 
are required to explain the binding mechanism between these variables. 
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Acknowledging the rate of suicide of people with COPD shows a 
remarkable need for intervention. However, suicide intervention is not a simple task, 
because it is considered a complex and multifactorial phenomenon which occurrence 
cannot be attributed to one single characteristic or event.52 Thus, family support 
through a multi-professional team is essential to improve the quality of life of these 
patients. Moreover, aiming to implement suicide surveillance policies, public 
agencies, especially in developing countries, should invest in the creation and 
development of databases for reporting this type of health event. 
In this review, all the studies included19,32-37 were found in databases of 
developed countries. However, it is known that the highest prevalence of suicide is 
found in low or medium income countries53, which often do not have a database on 
suicide.54 Thus, it is essential to invest in the creation and improvement of databases, 
especially in developing countries, because according to Lozano et al. (2012),23 the 
effects of the massive use of tobacco observed among men in such countries at the 
end of the last century will start to emerge and tends to increase COPD diagnoses. 
Another question related to secondary data is the criteria for diagnosing 
COPD, considering subtypes of this disease are acknowledged and characterize 
COPD as a heterogeneous disease55,56, but the studies included did not consider 
these differences. Pinto et al. (2015)56 considered the existence of two COPD 
phenotypes: one is observed in younger people and it is more prevalent in women, 
presenting no other comorbidities and a rapid decline in lung function. The other is 
associated with comorbidities (obesity, cardiovascular and metabolic alterations), and 
people with this phenotype appear to have worse health outcomes. Esteban et al. 
(2016)55 also considered a third phenotype with lower levels of dyspnea and 
comorbidities. 
Considering COPD is a complex disease55, it is essential to analyse these 
diferences and their relationships with the suicide outcome. This heterogeneity varies 
from younger participants, lower dyspnea scores, higher lung capacity and level of 
physical activity, lower comorbidities, and better quality of life (subtype A) to higher 
dyspnea scores, lower pulmonary function, lower quality of life and level of physical 
activity (subtype C), and higher rates of hospitalization (subtype D).55 
This is an important synthesis study that contributes to the overall 
cumulative knowledge from the following three points: It is the first systematic review 
in the literature to observe the likelihood of suicide in COPD patients, the high 
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methodological quality observed in the eligible studies provides credibility to the 
results obtained, presenting evidence level 3according to the Oxford Centre for 
Evidence Based Medicine57 and moderate quality of evidence according to GRADE30. 
 
Limitations 
Summarizing information from secondary data requires the awareness of 
the accuracy of such data, as observed in all the eligible studies of this systematic 
review.19,32-37 Besides the underreporting commonly associated with secondary data 
on suicide, there are also contextual issues (esteem and pressures in legal, religious, 
and political environments), diagnosis difficulties in some cases (self-starvation, falls, 
drownings, motor vehicle accidents, opiate overdose, euthanasia), and the lack of an 
internationally standardized procedure for suicide reporting.58 Another limitation 
related to secondary data is not considering the heterogeneity of COPD, which 
subtypes could be related to the suicide outcome, but are not informed 
separately.55,56 
This study is not free of limitations, including the low number of eligible 
studies and the heterogeneity among them, which is common in systematic reviews 
of observational studies. Moreover, the absence of studies performed in developing 
countries may have limited the external validity of the results of our meta-analysis for 
the global reality. 
 
CONCLUSION 
The findings of the present review allow concluding that COPD patients 
have a higher likelihood of suicide (1.9 times) than non-carriers of the disease. It is 
worth noting that COPD is a heterogeneous disease, which may delay diagnoses 
and treatment. Similarly, risk factors associated with suicide, such as mental 
disorders, are underdiagnosed and undertreated. 
 
Patients living with COPD form a group that requires attention from health 
teams and policymakers to prevent the suicide outcome. Implementing suicide 
prevention measures in this group of patients is of utmost importance, including 
psychological care and the adaptation of daily life activities, which should start along 
with the COPD diagnosis. 
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3 CONCLUSÂO 
Considerando-se o resultado desse estudo, a associação entre DPOC e 
maior risco de suicídio é real. Atualmente essas condições são importantes causas 
de mortalidade e morbidade no contexto mundial. Ressaltando-se ainda a 
expectativa de aumento nas suas prevalências. Tanto a DPOC quanto o suicídio, 
decorrente de condições secundários ou de transtornos mentais, são 
subdiagnosticados e subtratados. A DPOC apresenta manifestações clínicas 
insidiosas e agravadas progressivamente, o que em muitas situações atrasam o 
diagnóstico e o tratamento adequado. Da mesma forma, o suicídio e os transtornos 
mentais também são subestimados, marginalizados e têm seu diagnóstico e 
tratamento retardados. Nesse contexto, o diagnóstico tardio assim como o início do 
plano terapêutico dessas duas condições clínicas são responsáveis por prejuízos 
para a saúde individual das pessoas acometidas, suas famílias e para os setores 
previdenciário e assistencial à saúde. Além de contribuir no aumento da prevalência 
de suicídio e na piora da classificação de risco da DPOC. 
No campo da Promoção da Saúde a qualidade de vida é conceito 
fundamental. A DPOC, o suicídio e seus transtornos mentais reduzem essa 
qualidade de vida, e se não identificadas precocemente e implementadas medidas 
de mudança no estilo de vida, o risco de agravamento é maior.  Considerando-se o 
tabagismo como principal fator de risco para a DPOC, assim como a relação da 
dependência da nicotina e os transtornos depressivos e de ansiedade, são 
potencializadores do suicídio. 
 Assim, a DPOC, o tabagismo, o suicídio e a Saúde Mental são problemas 
de Gestão da Saúde Coletiva, e políticas direcionadas para essas condições podem 
contribuir para redução dessa morbidade e mortalidade. Sugerem-se políticas que 
incluam intensificação e consolidação das estratégias para auxílio no abandono do 
tabagismo contempladas na Promoção da Saúde. O incentivo à capacitação 
profissional médica na Atenção Primária à Saúde para o diagnóstico precoce e 
tratamento da DPOC, assim como acesso ao tratamento farmacológico com drogas 
e dispositivos inalatórios de primeira linha. A disponibilização de acompanhamento 
por equipe multiprofissional com  fisioterapeuta para a reabilitação respiratória, 
psicólogos e psiquiatras para avaliação da saúde mental e especialistas em 
pneumologia contemplando o princípio da integralidade. E finalmente a 
intensificação de medidas preventivas para o suicídio como acesso facilitado aos 
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equipamentos de saúde e/ou sociais, disponibilidade de  mecanismos tipo Mobile 
Health e campanhas de esclarecimento e desmistificação do suicídio. 
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